A Smart Wearable Device for Monitoring Urination Function in Benign Prostatic Hyperplasia

Condition(s) studied

Investigational drug(s) / intervention(s)

Electrical Impedance Tomography (EIT) Wearable Monitoring Device: A non-invasive, portable device that uses an array of surface electrodes placed on the lower abdomen to measure bioimpedance changes. It reconstructs real-time, three-dimensional images and volume data of the bladder during filling and voiding phases.

Study summary

Benign Prostatic Hyperplasia (BPH) is a common condition that can cause bothersome urination problems and reduce quality of life. Accurately measuring how the bladder empties is important for diagnosis and treatment, but current methods like uroflowmetry can be inconvenient and are done only at a clinic.

This study aims to test a new, non-invasive smart wearable device that uses Electrical Impedance Tomography (EIT) to monitor bladder function in patients with BPH. The device is worn on the lower abdomen. In this study, participants will use this EIT device while also undergoing the standard uroflowmetry test. The main goal is to see how well the measurements from the new device (like urine flow rate and volume) agree with those from the standard test.

The study hopes to show that this wearable device can accurately and comfortably track bladder function over time. If successful, it could lead to a new tool for doctors to better monitor patients with BPH, even potentially at home.

Eligibility

Primary outcome measure(s)

• Agreement of Voiding Parameters Between EIT Device and Uroflowmetry — From device placement until completion of the voiding test, assessed on the day of the single study visit.

Trial sites (1)

More Peking University Third Hospital trials in China

Other trials for the same condition